Jundishapur Journal of Microbiology

Published by: Kowsar

Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma

Abolfazl Akbari 1 , Zohreh Farahnejad 2 , Javad Akhtari 3 , Mahdi Abastabar 4 , Gholam Reza Mobini 5 and Amir Seied Ali Mehbod 2 , *
Authors Information
1 Colorectal Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Mycology, AJA University of Medical Sciences, Tehran, IR Iran
3 Immunogenetic Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
4 Department of Medical Mycology and Parasitology, Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
5 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2016, 9 (5); e60055
  • Published Online: March 5, 2016
  • Article Type: Research Article
  • Received: February 1, 2015
  • Revised: August 8, 2015
  • Accepted: October 19, 2015
  • DOI: 10.5812/jjm.27297

To Cite: Akbari A, Farahnejad Z, Akhtari J, Abastabar M, Mobini G R, et al. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma, Jundishapur J Microbiol. 2016 ; 9(5):e60055. doi: 10.5812/jjm.27297.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Gmeiner M, Sonnberger M, Wurm G, Weis S. Glioblastoma with the appearance of arteriovenous malformation: pitfalls in diagnosis. Clin Neurol Neurosurg. 2013; 115(5): 501-6[DOI][PubMed]
  • 2. Shahideh M, Fallah A, Munoz DG, Loch Macdonald R. Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients. J Clin Neurosci. 2012; 19(8): 1080-6[DOI][PubMed]
  • 3. Mohme M, Neidert MC, Regli L, Weller M, Martin R. Immunological challenges for peptide-based immunotherapy in glioblastoma. Cancer Treat Rev. 2014; 40(2): 248-58[DOI][PubMed]
  • 4. Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma multiforme. Biochim Biophys Acta. 2013; 1836(2): 236-44[DOI][PubMed]
  • 5. Akbari , , , , , , A, Amanpour SMH, Muhammadnejad S, Ghahremani MH, Ghaffari SH, Dehpour AR, et al. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma Daru 2014; 22: 47-53[DOI][PubMed]
  • 6. Mobini GR, Ghahremani MH, Amanpour S, Dehpour AR, Akbari A, Hoseiniharouni SM, Muhammadnejad S, Sheikhzade M, Abedkhojasteh H, et al. ransforming growth factor beta-induced factor 2-linked X (TGIF2LX) regulates two morphogenesis genes, Nir1 and Nir2 in human colorectal Acta Medica Iranica. 2016; 54(5): 302-307[DOI]
  • 7. Sheikhzade M, Akbari A, Karkhaneh R, Ghassemi F, Sadeghi AR, Shahrzad Kavakani M, Mobini GR, Mohebbi M, Heidari M. Digoxin inhibits retinoblastoma through suppressing a non-canonical TGFβ signaling pathway BJMMR 2016; 15(6): 1-10
  • 8. Akbari A, Ghahremani MH, Mobini GR, et al. Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208). Iran J Basic Med Sci 2015; 18(9): 856-861[DOI]
  • 9. Nauts HC, Fowler GA, Bogatko FH. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand Suppl. 1953; 276: 1-103[PubMed]
  • 10. Akbari A, Mobini GR, Maghsoudi R, Akhtari J, Faghihloo E, Farahnejad Z. Modulation of transforming growth factor-β signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B. Mol Med Rep. 2016; 13(1): 909-914[DOI][PubMed]
  • 11. Zacharski LR, Sukhatme VP. Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer? J Thromb Haemost. 2005; 3(3): 424-7[DOI][PubMed]
  • 12. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J. 2003; 79(938): 672-80[PubMed]
  • 13. Michl P, Buchholz M, Rolke M, Kunsch S, Löhr M, McClane B, et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology. 2001; 121(3): 678-84[PubMed]
  • 14. Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK. Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci. 2010; 17(1): 21[DOI][PubMed]
  • 15. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, et al. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Path. 2004; 164(5): 1627-33
  • 16. Gao Z, McClane BA. Use of Clostridium perfringens enterotoxin and the enterotoxin receptor-binding domain (C-CPE) for cancer treatment: opportunities and challenges. J Toxicol. 2011; 2012[DOI]
  • 17. Ansiaux R, Gallez B. Use of botulinum toxins in cancer therapy. Expert Opin Investig Drugs. 2007; 16(2): 209-18[DOI][PubMed]
  • 19. Hui J, Xiao F, Li H, Cui X, Liu H, Hu F. Inhibiting tumor-cell growth by novel truncated staphylococcal enterotoxin C2 mutant heng Wu Gong Cheng Xue Bao 2011; 27(6): 891-9[PubMed]
  • 18. Mahmoodzadeh Hosseini H, Ali Imani Fooladi A, Soleimanirad J, Reza Nourani M, Mahdavi M. Exosome/staphylococcal enterotoxin B, an anti tumor compound against pancreatic cancer. J BUON. 2014; 19(2): 440-8[PubMed]
  • 20. Reis LO, Ferreira U, Billis A, Cagnon VH, Favaro WJ. Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Guerin immunotherapy for nonmuscle invasive bladder cancer. J Urol. 2012; 187(2): 438-45[DOI][PubMed]
  • 21. Jung TY, Choi YD, Kim YH, Lee JJ, Kim HS, Kim JS, et al. Immunological characterization of glioblastoma cells for immunotherapy. Anticancer Res. 2013; 33(6): 2525-33[PubMed]
  • 22. Fuller CL, Braciale VL. Selective induction of CD8+ cytotoxic T lymphocyte effector function by staphylococcus enterotoxin B. J Immunol. 1998; 161(10): 5179-86[PubMed]
  • 23. Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C. Anthrax toxin: a tripartite lethal combination. FEBS Lett. 2002; 531(3): 384-8[PubMed]
  • 24. Raoofian R, Mojarrad M, Heidari M. Impact of TGIFLX expression on the regulation of BCL2 and BAX in prostate cancer cell line (LNCaP) British J Med & Med Res. 2013; 3(4): 953-961
  • 25. Engedal N, Skotland T, Torgersen ML, Sandvig K. Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol. 2011; 4(1): 32-46[DOI][PubMed]
  • 26. Bandala C, Perez-Santos JL, Lara-Padilla E, Delgado Lopez G, Anaya-Ruiz M. Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line. Asian Pac J Cancer Prev. 2013; 14(2): 891-4[PubMed]
  • 27. Brigotti M, Arfilli V, Carnicelli D, Rocchi L, Calcabrini C, Ricci F, et al. Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cells. Toxins (Basel). 2013; 5(2): 431-44[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments